Predicting breast cancer spread to bones
Part of Cancer, Skin clinical trials.
This study looks at medical records from breast cancer patients to create a tool that can better predict if and when the cancer might spread to the bones. By understanding these patterns, doctors may be able to catch bone metastases earlier and improve treatment plans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with breast cancer (confirmed by a biopsy).
- You are between 20 and 70 years old.
- You were first diagnosed between 2010 and 2020.
- The cancer had not spread to other parts of your body at the time of first diagnosis.
- You do not have other cancers, autoimmune diseases, or serious viral infections like HIV or hepatitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses information from women with newly diagnosed breast cancer that has spread (metastatic) to create a tool that helps predict how the disease may progress. By looking at your medical records, they hope to improve care and help future patients.
This study looks at people with cancer that has spread to the bones. It uses your medical imaging and records to understand your risk of bone fracture, without testing any new treatment.
This study looks at how different types of breast cancer spread to the bones, using bone scans. It may help doctors better understand and predict bone metastasis based on your cancer's specific characteristics.
This study follows adults with cancer that has spread to the bones and who are receiving radiation treatment. It looks at how interventional (procedure-based) treatment decisions affect outcomes by using information collected during routine care.
This trial uses a risk model to help detect if neuroblastoma has spread to the bone or bone marrow in newly diagnosed patients. It aims to improve how doctors identify metastasis without needing extra special tests.
This study looks at whether substances called metabolites in your blood and breast tissue can help predict if breast cancer has spread to the first lymph node (sentinel node). If you are scheduled for breast cancer surgery and have not had prior treatment, the study team will use your blood and tissue samples to try to improve prediction.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.